United for Answers: Leading ALS Organizations Announce ‘Champion Insights’ to Unlock Why Athletes and Military Members Face Higher ALS Risk
|

United for Answers: Leading ALS Organizations Announce ‘Champion Insights’ to Unlock Why Athletes and Military Members Face Higher ALS Risk

State-of-the-art remote-participation research seeks to understand how genetic factors linked to intense activities and lipid metabolism may increase ALS susceptibility NEW ORLEANS, August 13, 2025 — Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie’s Quest, today announced plans to launch Champion Insights, an ambitious research initiative designed to uncover critical…

Answer ALS Launches AI Drug Development Collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to Advance ALS Treatment Discovery
|

Answer ALS Launches AI Drug Development Collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to Advance ALS Treatment Discovery

NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health — a…

Behind the Mission: The Heartbeat of Answer ALS

Behind the Mission: The Heartbeat of Answer ALS

Terri Thompson’s Multidisciplinary Approach Terri Thompson didn’t set out to work in ALS research.  She had been working on a data-sharing platform for NASA, helping make research from spaceflight experiments easier for scientists to access and use. That experience opened the door to new collaborations, and eventually she was invited to join a group of…

Congress Passes Full-Year Continuing Appropriations Act, Delivering a Devastating Blow to ALS Research
|

Congress Passes Full-Year Continuing Appropriations Act, Delivering a Devastating Blow to ALS Research

Answer ALS is deeply alarmed and disappointed by Congress’ passage of the Full-Year Continuing Appropriations Act, which includes devastating cuts to ALS research funding. For years, funding for ALS research has grown steadily thanks to bipartisan support and the tireless efforts of the ALS community. These hard-fought increases have fueled groundbreaking progress in understanding ALS,…

ALS Therapy Development Institute, Answer ALS, and Microsoft Announce Groundbreaking Data Sharing Collaboration
|

ALS Therapy Development Institute, Answer ALS, and Microsoft Announce Groundbreaking Data Sharing Collaboration

The ALS Therapy Development Institute (ALS TDI), Answer ALS, and Microsoft are pleased to announce a collaboration that will bring together the two largest existing clinical and omics data sets relating to ALS. Through this partnership, comprehensive data collected through ALS TDI’s ALS Research Collaborative (ARC) will be added to Neuromine, an innovative data portal…

ANSWER ALS ANNOUNCES DR. JEFFREY KELLER TO LEADERSHIP OF THEIR UNPRECEDENTED OPEN ACCESS ALS DATA REPOSITORY
|

ANSWER ALS ANNOUNCES DR. JEFFREY KELLER TO LEADERSHIP OF THEIR UNPRECEDENTED OPEN ACCESS ALS DATA REPOSITORY

Dr. Jeffrey Keller to Co-Lead Answer ALS’ Unprecedented Open Access ALS Data Repository. Appointment to Answer ALS bridges revolutionary data repository with renowned biomedical research center. NEW ORLEANS, Louisiana—Answer ALS is excited to announce that Dr. Jeffrey Keller, Ph.D. has been selected as Answer ALS’ Principal Investigator over the program’s renowned open-access data repository, Neuromine….

2023 Year In Review

2023 Year In Review

10 Years of Commitments Met. Ten years ago, Answer ALS didn’t have a name, but the plan was developed to empower researchers around the world to help bring an end to ALS. In the video below, created when the program first began, every commitment made has been or is being met. Through a massive coordination…

Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects
|

Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects

ALS Motor Neurons Differ by Sex, Study Finds. A new Cedars-Sinai study in collaboration with the University of California, Irvine (UCI) and the Answer ALS consortium has examined the expression of thousands of genes in stem cell-generated motor neurons that are known to die in patients with ALS. The study, published in the peer-reviewed journal…

Danielle Boyce Slated to Lead Answer ALS Research

Danielle Boyce Slated to Lead Answer ALS Research

Answer ALS is excited to announce Danielle Boyce, DPA, MPH as the new Executive Director for Answer ALS Research, coupled with her roles as Executive Director for the Packard Center, and Assistant Professor of Neurology at Johns Hopkins. Danielle brings 20-years of experience as a researcher, patient advocate, public speaker and author. “Danielle is a…